This is a Clayton news story, published by CNBC.
For more Clayton news, you can click here:
more Clayton newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from CNBC, you can click here:
more news from CNBCOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Novo Nordisk. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest new manufacturing plant news, blockbuster weight loss drug Wegovy news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Novo Nordisk spokespersonCNBC
•79% Informative
The investment will fund a new manufacturing plant in Clayton , North Carolina , responsible for filling and packaging syringes and injection pens for the drugs.
Demand for Wegovy and Ozempic has outstripped supply over the last year , spurring intermittent shortages in the U.S. Danish drugmaker plans to invest $6.8 billion in production this year , up from roughly $4 billion last year .
VR Score
77
Informative language
77
Neutral language
20
Article tone
formal
Language
English
Language complexity
65
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
2
Source diversity
2
Affiliate links
no affiliate links